SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-24-049993
Filing Date
2024-04-22
Accepted
2024-04-22 16:12:17
Documents
7
Period of Report
2024-06-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2410797d15_def14a.htm DEF 14A 193777
2 GRAPHIC j241079718_ba001.jpg GRAPHIC 16040
3 GRAPHIC j241079718_ba002.jpg GRAPHIC 5491
4 GRAPHIC j241079718_ba003.jpg GRAPHIC 4394
5 GRAPHIC j241079718_ba004.jpg GRAPHIC 5491
6 GRAPHIC tm2410797d15_hqlimg001.jpg GRAPHIC 142160
7 GRAPHIC tm2410797d15_hqlimg002.jpg GRAPHIC 150723
  Complete submission text file 0001104659-24-049993.txt   642460
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Filer) CIK: 0000884121 (see all company filings)

IRS No.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 811-06565 | Film No.: 24861333